{
  "actions": [
    {
      "acted_at": "2023-03-03",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2023-03-03",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2023-03-10",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr1375-118",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "H001090",
      "district": "9",
      "name": "Harder, Josh",
      "original_cosponsor": false,
      "sponsored_at": "2023-04-13",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "K000380",
      "district": "8",
      "name": "Kildee, Daniel T.",
      "original_cosponsor": false,
      "sponsored_at": "2023-03-27",
      "state": "MI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "K000382",
      "district": "2",
      "name": "Kuster, Ann M.",
      "original_cosponsor": false,
      "sponsored_at": "2023-03-23",
      "state": "NH",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001204",
      "district": "9",
      "name": "Meuser, Daniel",
      "original_cosponsor": true,
      "sponsored_at": "2023-03-03",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000620",
      "district": "7",
      "name": "Pettersen, Brittany",
      "original_cosponsor": false,
      "sponsored_at": "2023-06-20",
      "state": "CO",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-03-03",
  "number": "1375",
  "official_title": "To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s607-118",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "EFFECTIVE Act",
  "sponsor": {
    "bioguide_id": "T000483",
    "district": "6",
    "name": "Trone, David J.",
    "state": "MD",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-03-03",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2023-03-03",
    "date": "2023-07-21T21:20:38Z",
    "text": "Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act\n\nThis bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug (i.e., opioid medication) upon a determination that the drug does not provide a significant advantage with respect to safety or effectiveness as compared to other drugs."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "EFFECTIVE Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "EFFECTIVE Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To allow the Secretary of Health and Human Services to deny approval of a new drug application for an opioid analgesic drug on the basis of such drug not being clinically superior to other commercially available drugs.",
      "type": "official"
    }
  ],
  "updated_at": "2025-08-06T04:24:41Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/hr/BILLSTATUS-118hr1375.xml"
}